BOARD/COMMISSION:  MN Drug Formulary Committee

At least five licensed physicians actively engaged in the practice of medicine in Minnesota

• One of whom is an actively practicing psychiatrist,
• One of whom specializes in the diagnosis and treatment of rare diseases
• One of whom specializes in pediatrics,
• And one of whom actively treats persons with disabilities

At least three licensed pharmacists actively engaged in the practice of pharmacy in Minnesota

• One of whom practices outside the metropolitan counties listed in section 473.121, subdivision 4,
• One of whom practices in the metropolitan counties listed in section 473.121, subdivision 4,
• And one of whom is a practicing hospital pharmacist;

At least two consumer representatives, all of whom must have a personal or professional connection to medical assistance;

And one representative designated by the Minnesota Rare Disease Advisory Council established under section 256.4835;

The remainder to be made up of healthcare professionals who are licensed in their field and have recognized knowledge in the clinically appropriate prescribing, dispensing, and monitoring of covered outpatient drugs.

Members of the Formulary Committee shall not be employed by the Department of Human Services or have a personal interest in a pharmaceutical company, pharmacy benefits manager, health plan company, or their affiliate organizations, but the committee shall be staffed by an employee of the department who shall serve as an ex officio, nonvoting member of the committee.

For the purposes of this subdivision, "personal interest" means that a person owns at least five percent of the voting interest or equity interest in the entity, the equity interest owned by a person represents at least five percent of that person's net worth, or more than five percent of a person's gross income for the preceding year was derived from the entity.

A committee member must notify the committee of any potential conflict of interest and recuse themselves from any communications, discussion, or vote on any matter where a conflict of interest exists. A conflict of interest alone, without a personal interest, does not preclude an applicant from serving as a member of the Formulary Committee. 

Per the new M.S. 256B0625, Subd. 13., the formulary committee is designated by the commissioner to carry out duties as described in M.S. 256B.0625, subds 13-13G. These include reviewing the over-the-counter drugs and making recommendations about prior authorization. The committee also still establishes the list of drugs excluded from mandatory generic substitution under MS 151.21.